Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists

The invention relates to benzimidazole-carboxamide 5-HT4 receptor agonist compounds of formula (I)wherein R1 and X are as defined in the specification, or a pharmaceutically acceptable salt or solvate or stereoisomer thereof. The invention also relates to pharmaceutical compositions comprising such...

Full description

Saved in:
Bibliographic Details
Main Author McKinnell, Robert Murray
Format Patent
LanguageEnglish
Published 30.06.2020
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
METALLURGY
ORGANIC CHEMISTRY
PHYSICS
TESTING
Online AccessGet full text

Cover

More Information
Summary:The invention relates to benzimidazole-carboxamide 5-HT4 receptor agonist compounds of formula (I)wherein R1 and X are as defined in the specification, or a pharmaceutically acceptable salt or solvate or stereoisomer thereof. The invention also relates to pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
Bibliography:Application Number: US201916260984